Treatment with Optimal Dose Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Has a Positive Effect on Long-Term Survival in Older Individuals (Aged >70 Years) and Octogenarians with Systolic Heart Failure. [electronic resource]
Producer: 20170817Description: 675-83 p. digitalISSN:- 1179-1969
- Aged
- Aged, 80 and over
- Angiotensin Receptor Antagonists -- administration & dosage
- Angiotensin-Converting Enzyme Inhibitors -- administration & dosage
- Cohort Studies
- Dose-Response Relationship, Drug
- Female
- Heart Failure, Systolic -- drug therapy
- Humans
- Male
- Middle Aged
- Proportional Hazards Models
- Survivors
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.